Yurong Guo
Senior Director - Analytical Development & Quality Control Arcturus Therapeutics
Seminars
Wednesday 25th February 2026
Roundtable Discussion: Translating Complex mRNA Characterization Assays into QC-Ready Strategies to Reduce Downtime between Teams
9:30 am
- How to adapt AD assays into validated QC workflows to ensure reproducibility across sites and manufacturing scales
- How to overcome challenges of assay transfer, variability, and lack of reference standards to safeguard consistency and compliance
- How to embed standardized characterization workflows to support smoother regulatory submissions, tech transfer and global comparability
Wednesday 25th February 2026
Next Generation RNA Medicines: STARR® Self-Amplifying mRNA Vaccines
12:00 pm
- Differences between Arcturus sa-mRNA and approved mRNA vaccines
- EMA Approval Case Studies:
- Characterization of mRNA
- Fragments in Drug Substance
- Efficacy/tolerability of mRNA Fragments In Vivo
- Lipid Mass Balance
- Future Perspectives
